The basic principles of tumor vaccine success include the delivery of large amounts of high-quality antigens to DCs, the induction of strong and sustained CD4+ T helper cells and cytotoxic T lymphocyte (CTL) responses through the activation of DCs, and the persistent infiltration of the TME [16]. This evidence concerns the gene CD4 and neoplasm.